Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.

The Rozanolixizumab market offers significant opportunities driven by increasing autoimmune disorders like generalized ...

An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...

Scientists have used their discovery of previously unknown mechanisms in an anti-inflammatory pathway to develop a powerful upgrade: an engineered antibody that delivers the effectiveness of IVIG at ...

An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that ...

The third quarter 2025 financial results and business update will be discussed during a conference call and webcast presentation today at 1:30 pm CET/8:30 am ET. A webcast of the live call and replay ...

SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada has issued a ...

Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver ...

Researchers are now linking eye health to heart health, suggesting that retinal scans could help predict cardiovascular risk ...

Global Monoclonal Antibody Therapeutics Market OverviewThe global monoclonal antibody therapeutics market is poised for substantial expansion, projected to grow at a CAGR of approximately 12% over the ...

An excessive accumulation of fat in the abdominal area in middle-aged women is a risk factor for cognitive decline, say scientists.